ReviewPediatric pulmonology2026
The Genetics of Primary Ciliary Dyskinesia - Advances and Limitations.
Review in Pediatric pulmonology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
introductionPrimary ciliary dyskinesia (PCD) is a genetic condition that is caused by variants in genes associated with motile cilia. Most individuals with PCD present early in life with symptoms of chronic cough, nasal congestion, and recurrent upper and lower respiratory tract infections. About 50% of patients have laterality defects and cardiac malformation including heterotaxy syndrome, and most individuals have sub-infertility.
methodsThis narrative review synthesizes available evidence on the genes associated with PCD with emphasis on the differences in the effects on cilia structure and function.
resultsPathogenic variants in over 60 genes cause PCD. Many of these genes encode structural components within the ciliary axoneme, while others encode cytoplasmic assembly and regulatory proteins crucial for the normal function of cilia. Recent identification of variants in genes that are associated with both motile and sensory cilia function have expanded our understanding of the clinical manifestations of ciliopathies. Genetic confirmation is encouraged by the recent European Respiratory and American Thoracic societies diagnostic guidelines. The expanded use of genetic approaches and identification of variants of unknown significant in many genes associated with PCD emphasize the need for better diagnostic tools for PCD.
conclusionPCD is a complex genetic condition. Recognizing the clinical symptoms associated with PCD and establishing a genetic diagnosis is crucial for early initiation of proper treatment and for differentiating PCD from other conditions with similar symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.